3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
10
Active not recruiting
5
Withdrawn
2
Recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
19
Breast
7
Gastrointestinal
5
Genitourinary
4
Thoracic
3
Tumor-Agnostic
2
Head & Neck
2
Sarcoma
1
Dermatologic
1
Conditions
Neoplasms
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Interventions
Doxorubicin
25
Radiotherapy
16
apatinib
15
Cyclophosphamide
15
Ifosfamide
13
anlotinib
12
camrelizumab
10
Temozolomide
9
Imatinib Mesylate
9
Vincristine
8
Surgical Procedures, Operative
7
Neoadjuvant Therapy
7
Methotrexate
7
Drug Therapy
7
Dactinomycin
5
Blood Specimen Collection
5
fludarabine phosphate
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Etoposide
4
Docetaxel
4
Carboplatin
4
toripalimab
3
pembrolizumab
3
Trabectedin
3
Topotecan
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
olaparib
×
Sarcoma
×
Clear all
NCT03570437
2022-03-02
COPELIA
University of Manchester
Phase 2
Unknown
124 enrolled